Micro Emerging Active

TWST insider selling

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
3
Sources
2

Top Movers

TickerSectorChange
TWST
Healthcare+56.6%

Sentiment Timeline

Sector Performance

Stock Performance

Event Timeline

Jul 19, 2026
Cathie Wood Is Selling This High-Flying Stock. Is It a Buy? Bearish
Jun 26, 2026
From Quantum to Clothing: Insider Trades Hit 3 Big Names Neutral
Jun 06, 2026
Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does … Neutral

Related Articles

Cathie Wood Is Selling This High-Flying Stock. Is It a Buy?

Nasdaq · Jul 19, 2026
Mixed

Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for …

Nasdaq · Jun 06, 2026
Bearish
🤖

AI Overview

What happened: Cathie Wood's Ark ETFs sold over $11 million worth of Twist Biosciences stock on June 30, 2026, with shares up 190% YTD. Simultaneously, Twist's Chief Legal Officer, Dennis Cho, sold 14,205 shares on May 29, 2026, for approximately $991,000. Both sales were significant but not unusual for insiders, with Wood's move likely due to portfolio management.

Market impact: The insider selling at Twist Biosciences, a synthetic DNA manufacturer, has raised eyebrows among investors. While not indicative of any fundamental issues, it may trigger profit-taking and valuation repricing in the stock, affecting other high-flying biotech and genomics companies.

What to watch next: Twist Biosciences' Q2 earnings report on August 10, 2026, will provide insights into the company's financial health and growth prospects. Additionally, any further insider trading activity or changes in Ark ETFs' holdings will be crucial to monitor, as they could signal broader trends in the sector.
AI Overview as of Jul 19, 2026

Timeline

First SeenJul 19, 2026
Last UpdatedAug 22, 2026